Effects of testosterone therapy on muscle performance and physical function in older men with mobility limitations (The TOM Trial): Design and methods
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
The TOM study is the first, single-site, placebo-controlled, randomized clinical trial designed to comprehensively determine the effects of testosterone administration on muscle strength and physical function in older men with mobility limitations. A total of 252 community dwelling individuals aged 65 and older with low testosterone levels and self-reported limitations in mobility and short physical performance battery (SPPB) score between 4 and 9 will be randomized to receive either placebo or testosterone therapy for 6 months. The primary objective is to determine whether testosterone therapy improves maximal voluntary muscle strength as quantified by the one repetition maximum. Secondary outcomes will include measures of physical function (walking, stair climbing and a lifting and lowering task), habitual physical activity and self-reported disability. The effects of testosterone on affect, fatigue and sense of well being will also be assessed. Unique aspects of the TOM Trial include selection of men with self-reported as well as objectively demonstrable functional limitations, community-based screening and recruitment, adjustment of testosterone dose to ensure serum testosterone levels in the target range while maintaining blinding, and inclusion of a range of self-reported and performance-based physical function measures as outcomes. Clinicaltrials.gov identifier: NCT00240981.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Development of a fatigue scale
Chalder, T., Berelowitz, G., Pawlikowska, T., Watts, L., Wessely, S., Wright, D., & Wallace, E. P. (1993) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(93)90081-p · Cited by 3,032 · cited 3×
“3.7.3 Tertiary Study Outcomes—Sense of well being, affect, and fatigue will be assessed by using the following validated instruments: Psychological Well Being Index [39], Derogatis Affects Balance Scale [40], and the Chalder Fatigue Scale [41], respectively.”
MethodInfluentialWilson, I. B. (1995) · JAMA · doi:10.1001/jama.1995.03520250075037 · Cited by 3,027 · cited 1×
“Demonstrable limitations in these activities are strongly predictive of falls [2], disability [3], hospitalization [4], quality of life [5] and even mortality [6,7].”
BackgroundThe effects of supraphysiologic doses of testosterone on muscle size and strength in normal men
Bhasin, S., Storer, T. W., Berman, N., Callegari, C., Clevenger, B., Phillips, J., Bunnell, T. J., Tricker, R., Shirazi, A., & Casaburi, R. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607043350101 · Cited by 1,659
Self-citationPhysical performance measures in the clinical setting
Studenski, S., Perera, S., Wallace, D., Chandler, J. M., Duncan, P. W., Rooney, E., Fox, M., & Guralnik, J. M. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2003.51104.x · Cited by 1,218 · cited 2×
“Demonstrable limitations in these activities are strongly predictive of falls [2], disability [3], hospitalization [4], quality of life [5] and even mortality [6,7].”
BackgroundTestosterone dose-response relationships in healthy young men
Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Bhasin, D., Berman, N., Chen, X., Yarasheski, K. E., Magliano, L., Dzekov, C., et al. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1172 · Cited by 967 · cited 1×
“The gradual but progressive decrease in serum testosterone from age 20 to 80 [14–16] and indisputable evidence that testosterone supplementation increases skeletal muscle mass not only in states of health [17,18], but also disease [19–22] and older age [23–26], have underscored its potential as a function promoting an…”
BackgroundSelf-citationNewman, A. B., Simonsick, E. M., Naydeck, B. L., Boudreau, R. M., Kritchevsky, S. B., Nevitt, M. C., Pahor, M., Satterfield, S., Brach, J. S., Studenski, S. A., et al. (2006) · JAMA · doi:10.1001/jama.295.17.2018 · Cited by 934
Strength, power and related functional ability of healthy people aged 65-89 years.
SKELTON, D. A., GREIG, C. A., DAVIES, J. M., & YOUNG, A. (1994) · Age and Ageing · doi:10.1093/ageing/23.5.371 · Cited by 934 · cited 1×
“This is founded on observations that age-related changes in skeletal muscle mass are paralleled by changes in strength and power [8–10]; two variables associated with performance in measures of mobility such as gait speed, stair climb time or repeated chair rise time [11–13].”
BackgroundImprovement in usual gait speed predicts better survival in older adults
Hardy, S. E., Perera, S., Roumani, Y. F., Chandler, J. M., & Studenski, S. A. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01413.x · Cited by 628 · cited 2×
“Demonstrable limitations in these activities are strongly predictive of falls [2], disability [3], hospitalization [4], quality of life [5] and even mortality [6,7].”
BackgroundTestosterone administration to elderly men increases skeletal muscle strength and protein synthesis
Urban, R. J., Bodenburg, Y. H., Gilkison, C., Foxworth, J., Coggan, A. R., Wolfe, R. R., & Ferrando, A. (1995) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1995.269.5.e820 · Cited by 608
Cited by
Adverse Events Associated with Testosterone Administration
Basaria, S., Coviello, A. D., Travison, T. G., Storer, T. W., Farwell, W. R., Jette, A. M., Eder, R., Tennstedt, S., Ulloor, J., Zhang, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000485 · Cited by 1,494
Self-citationTravison, T. G., Basaria, S., Storer, T. W., Jette, A. M., Miciek, R., Farwell, W. R., Choong, K., Lakshman, K., Mazer, N. A., Coviello, A. D., et al. (2011) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glr100 · Cited by 160
“Methods The trial’s design and safety results have been published (22,23).”
BackgroundMethodSelf-citationCawthon, P. M., Travison, T. G., Manini, T. M., Patel, S., Pencina, K. M., Fielding, R. A., Magaziner, J. M., Newman, A. B., Brown, T., Kiel, D. P., et al. (2020) · The Journals of Gerontology Series A · doi:10.1093/gerona/glz081 · Cited by 127
Self-citationHuang, G., Basaria, S., Travison, T. G., Ho, M. H., Davda, M., Mazer, N. A., Miciek, R., Knapp, P. E., Zhang, A., Collins, L., et al. (2014) · Menopause · doi:10.1097/gme.0000000000000093 · Cited by 119
Self-citationCertainly More Guidelines than Rules
McLachlan, R. I. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0838 · Cited by 18
Metadata
- Authors
- LeBrasseur, N. K., Lajevardi, N., Miciek, R., Mazer, N., Storer, T. W., & Bhasin, S.
- Venue
- Contemporary Clinical Trials
- Publisher
- Elsevier BV
- Published
- 2009-03
- Volume
- 30
- Issue
- 2
- Pages
- 133-140
- ISSN
- 1551-7144 (ISSN-L)
- OpenAlex
- W2072781234
- Cited by
- 34
- References
- 22
- FWCI
- 1.53
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.